Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma / N.W.C.J. van de Donk, N. Kröger, U. Hegenbart, P. Corradini, J.F. San Miguel, H. Goldschmidt, J.A. Perez-Simon, M. Zijlmans, R.A. Raymakers, V. Montefusco, F.A. Ayuk, M.H. J. van Oers, A. Nagler, L.F. Verdonck, H.M. Lokhorst. - In: BLOOD. - ISSN 0006-4971. - 107:8(2006 Apr), pp. 3415-3416.
Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma
P. Corradini;
2006
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
